| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Paula Barreras, Eleni S Vasileiou, Angeliki G Filippatou, Kathryn C Fitzgerald, Michael Levy, Carlos A Pardo, Scott D Newsome, Ellen M Mowry, Peter A Calabresi, Elias S Sotircho. Long-term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease. Neurology. 2022-10-14. PMID:36240094. |
rituximab is used widely for relapse prevention in neuromyelitis optica spectrum disorder (nmosd) and myelin oligodendrocyte glycoprotein (mog)-igg associated disease (mogad), however data regarding the effectiveness and safety of long-term rituximab use in these conditions are limited. |
2022-10-14 |
2023-08-14 |
Not clear |
| Eva Maria Wendel, Helen Sophie Thonke, Annikki Bertolini, Matthias Baumann, Astrid Blaschek, Andreas Merkenschlager, Michael Karenfort, Barbara Kornek, Christian Lechner, Daniela Pohl, Martin Pritsch, Kathrin Schanda, Mareike Schimmel, Charlotte Thiels, Stephan Waltz, Gert Wiegand, Banu Anlar, Nina Barisic, Christian Blank, Markus Breu, Philip Broser, Adela Della Marina, Katharina Diepold, Matthias Eckenweiler, Astrid Eisenkölbl, Michael Freilinger, Ursula Gruber-Sedlmayr, Annette Hackenberg, Tobias Iff, Ellen Knierim, Johannes Koch, Georg Kutschke, Steffen Leiz, Grischa Lischetzki, Margherita Nosadini, Alexander Pschibul, Edith Reiter-Fink, Doris Rohrbach, Michela Salandin, Stefano Sartori, Jan-Ulrich Schlump, Johannes Stoffels, Jurgis Strautmanis, Daniel Tibussek, Victoria Tüngler, Norbert Utzig, Markus Reindl, Kevin Rostás. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome. Neurology(R) neuroimmunology & neuroinflammation. vol 9. issue 6. 2022-10-13. PMID:36229191. |
the spectrum of myelin oligodendrocyte glycoprotein (mog) antibody-associated disorder (mogad) comprises monophasic diseases such as acute disseminated encephalomyelitis (adem), optic neuritis (on), and transverse myelitis and relapsing courses of these presentations. |
2022-10-13 |
2023-08-14 |
Not clear |
| Azita Soltanmohammadi, Maryam Jadid Tavaf, Simin Zargarani, Esmaeil Yazdanpanah, Bizhan Sadighi-Moghaddam, Bahman Yousefi, Hamid Reza Sameni, Dariush Haghmora. Daphnetin alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating Th2 and regulatory T cells. Acta neurobiologiae experimentalis. vol 82. issue 3. 2022-10-10. PMID:36214710. |
eae was induced with a subcutaneous injection of a combination of myelin oligodendrocyte glycoprotein (mog) and complete freund's adjuvant. |
2022-10-10 |
2023-08-14 |
mouse |
| Mohini Agrawal, Sandeep Shankar, Sunandan Bhatt. Neuromyelitis optica spectrum disorder with negative aquaporin-4 antibodies and positive anti-myelin oligodendrocyte glycoprotein antibodies: A case report. Medical journal, Armed Forces India. vol 78. issue Suppl 1. 2022-09-23. PMID:36147390. |
its diagnostic criteria have broadened the knowledge of this particular disease including the atypical cases where antiaquaporin-4 antibody is negative and anti-myelin oligodendrocyte glycoprotein (mog) antibody is positive. |
2022-09-23 |
2023-08-14 |
Not clear |
| Ünsal Yılmaz, Kıvılcım Gücüyener, Merve Yavuz, İbrahim Öncel, Mehmet Canpolat, Sema Saltık, Olcay Ünver, Ayşegül Neşe Çıtak Kurt, Ayşe Tosun, Sanem Yılmaz, Bilge Özgör, İlknur Erol, Ülkühan Öztoprak, Duygu Aykol Elitez, Meltem Çobanoğulları Direk, Muhittin Bodur, Serap Teber, Banu Anla. Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 41. 2022-09-22. PMID:36137476. |
the discovery of anti-myelin oligodendrocyte glycoprotein (mog)-igg and anti-aquaporin 4 (aqp4)-igg and the observation on certain patients previously diagnosed with multiple sclerosis (ms) actually have an antibody-mediated disease mandated re-evaluation of pediatric ms series. |
2022-09-22 |
2023-08-14 |
Not clear |
| Kate A Parham, Xiu Xia Sherry Tan, Daniel M Morelli, Lika Chowdhury, Heather C Craig, Steven M Kerfoo. Pre-Germinal Center Interactions with T Cells Are Natural Checkpoints to Limit Autoimmune B Cell Responses. Journal of immunology (Baltimore, Md. : 1950). 2022-09-19. PMID:36122934. |
using mouse model ag systems, we directly observed interactions between t and b cells responding to the self-antigen myelin oligodendrocyte glycoprotein (mog) and found that they are of lower quality compared with interactions between cells responding to the model foreign ag nitrophenyl-haptenated ova. |
2022-09-19 |
2023-08-14 |
mouse |
| Sufang Lin, Weiwei Long, Jialun Wen, Qiru Su, Jianxiang Liao, Zhanqi H. Myelin oligodendrocyte glycoprotein antibody-associated aseptic meningitis without neurological parenchymal lesions: A novel phenotype. Multiple sclerosis and related disorders. vol 68. 2022-09-17. PMID:36115288. |
myelin oligodendrocyte glycoprotein (mog) antibodies mediate inflammatory demyelinating diseases of the central nervous system. |
2022-09-17 |
2023-08-14 |
Not clear |
| Xiang-Dong Zeng, Hui Chen, Wen-Guang H. Myelin Oligodendrocyte Glycoprotein (MOG) antibody-associated meningoencephalitis due to Mycoplasma pneumoniae infection. Neurological research. 2022-09-16. PMID:36111693. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated meningoencephalitis due to mycoplasma pneumoniae infection. |
2022-09-16 |
2023-08-14 |
Not clear |
| Xiang-Dong Zeng, Hui Chen, Wen-Guang H. Myelin Oligodendrocyte Glycoprotein (MOG) antibody-associated meningoencephalitis due to Mycoplasma pneumoniae infection. Neurological research. 2022-09-16. PMID:36111693. |
although myelin oligodendrocyte glycoprotein (mog) antibody-associated disorders include a wide spectrum of syndromes, manifestations with meningoencephalitis symptoms due to |
2022-09-16 |
2023-08-14 |
Not clear |
| Iro Triantafyllakou, Nausicaa Clemente, Ravi Kumar Khetavat, Umberto Dianzani, Theodore Tselio. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG Molecular pharmaceutics. 2022-09-13. PMID:36098508. |
development of plga nanoparticles with a glycosylated myelin oligodendrocyte glycoprotein epitope (mog multiple sclerosis (ms) is one of the most common neurodegenerative diseases in young adults, with early clinical symptoms seen in the central nervous system (cns) myelin sheaths due to an attack caused by the patient's immune system. |
2022-09-13 |
2023-08-14 |
Not clear |
| Cristina M Gaudioso, Soe Mar, T Charles Casper, Rachel Codden, Adam Nguyen, Gregory Aaen, Leslie Benson, Tanuja Chitnis, Carla Francisco, Mark P Gorman, Manu S Goyal, Jennifer Graves, Benjamin M Greenberg, Janace Hart, Lauren Krupp, Timothy Lotze, Sona Narula, Sean J Pittock, Mary Rensel, Moses Rodriguez, John Rose, Teri Schreiner, Jan-Mendelt Tillema, Amy Waldman, Bianca Weinstock-Guttman, Yolanda Wheeler, Emmanuelle Waubant, Eoin P Flanaga. MOG and AQP4 antibodies among children with multiple sclerosis and controls. Annals of neurology. 2022-09-11. PMID:36088544. |
to determine the frequency of myelin oligodendrocyte glycoprotein (mog)-igg and aquaporin-4 (aqp4)-igg among pediatric-onset multiple sclerosis (poms) patients and healthy controls, determine whether seropositive cases fulfilled their respective diagnostic criteria, compare characteristics and outcomes in children with poms vs mog-igg-associated disease (mogad), and identify clinical features associated with final diagnosis. |
2022-09-11 |
2023-08-14 |
Not clear |
| Shizuka Yamamoto, Mitsutake Yano, Yuko Miyamoto, Takuya Hanaoka, Yoshihiro Nishida, Yasushi Kawan. The Postpartum Period Can Worsen Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalomyelitis: A Case Report. Internal medicine (Tokyo, Japan). 2022-09-07. PMID:36070939. |
myelin oligodendrocyte glycoprotein (mog) antibodies are associated with relapsing inflammatory demyelinating disease. |
2022-09-07 |
2023-08-14 |
Not clear |
| Vivek Satyasi, Gayatra Mainali, Jahnavi Chatterjee, Sita Paude. Encephalitis with Extensive Cortical Brain Magnetic Resonance Imaging Changes Secondary to Myelin Oligodendrocyte Glycoprotein Antibody Disease. The American journal of case reports. vol 23. 2022-08-31. PMID:36044392. |
background the relatively new autoimmune disorder, anti-myelin oligodendrocyte glycoprotein (mog) disease is particularly interesting because of its broad range of presentations. |
2022-08-31 |
2023-08-14 |
Not clear |
| b' Gemma Oliv\\xc3\\xa9-Cirera, Maria Jes\\xc3\\xbas Mart\\xc3\\xadnez-Gonz\\xc3\\xa1lez, Thais Armangu\\xc3\\xa. Pearls & Oy-sters: Tumefactive Demyelinating Lesions With MOG Antibodies Preceding Late-Infantile Metachromatic Leukodystrophy. Neurology. 2022-08-30. PMID:36041866.' |
we report a child that developed this clinico-radiological pattern associated with myelin oligodendrocyte glycoprotein (mog) antibodies several months prior the onset of progressive symptoms of late infantile mld. |
2022-08-30 |
2023-08-14 |
Not clear |
| Mariella Errede, Tiziana Annese, Valentina Petrosino, Giovanna Longo, Francesco Girolamo, Ignazio de Trizio, Antonio d'Amati, Antonio Uccelli, Nicole Kerlero de Rosbo, Daniela Virgintin. Microglia-derived CCL2 has a prime role in neocortex neuroinflammation. Fluids and barriers of the CNS. vol 19. issue 1. 2022-08-30. PMID:36042496. |
in myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae), several areas of demyelination are detectable in mouse cerebral cortex, where neuroinflammation events are associated with scarce inflammatory infiltrates and blood-brain barrier (bbb) impairment. |
2022-08-30 |
2023-08-14 |
mouse |
| Andrey E Urusov, Kseniya S Aulova, Pavel S Dmitrenok, Valentina N Buneva, Georgy A Nevinsk. Experimental Autoimmune Encephalomyelitis of Mice: Enzymatic Cross Site-Specific Hydrolysis of H4 Histone by IgGs against Histones and Myelin Basic Protein. International journal of molecular sciences. vol 23. issue 16. 2022-08-26. PMID:36012448. |
five igg preparations against histones (h4, h1, h2a, h2b, and h3) and against mbp corresponding to different spontaneous, mog (myelin oligodendrocyte glycoprotein of mice), and dna-histones that accelerated onset, acute, and remission stages of experimental autoimmune encephalomyelitis (eae; model of human multiple sclerosis) development were obtained from eae-prone c57bl/6 mice by several affinity chromatographies. |
2022-08-26 |
2023-08-14 |
mouse |
| Jie Fu, Lilei Peng, Yang Yang, Yang Xie, Zuoxiao Li, Benbing Ron. Case report: Overlapping syndrome mimicking infectious meningoencephalitis in a patient with coexistent MOG, NMDAR, mGluR5 antibody positivity. Frontiers in immunology. vol 13. 2022-08-22. PMID:35990698. |
his csf was positive for anti-myelin oligodendrocyte glycoprotein (mog), anti-n-methyl-d-aspartate receptor (nmdar) and anti-metabotropic glutamate receptor 5 (mglur5) antibodies. |
2022-08-22 |
2023-08-14 |
Not clear |
| Madhumati Otiv, Abhijeet Botre, Pawan Sha. Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. Therapeutic advances in vaccines and immunotherapy. vol 10. 2022-08-15. PMID:35966175. |
myelin oligodendrocyte glycoprotein (mog), a surface myelin protein, is the target of the immune system in this disease. |
2022-08-15 |
2023-08-14 |
Not clear |
| Erin Longbrak. Myelin Oligodendrocyte Glycoprotein-Associated Disorders. Continuum (Minneapolis, Minn.). vol 28. issue 4. 2022-08-08. PMID:35938661. |
anti-myelin oligodendrocyte glycoprotein (mog) autoantibodies have become a recognized cause of a pathophysiologically distinct group of central nervous system (cns) autoimmune diseases. |
2022-08-08 |
2023-08-14 |
Not clear |
| Ki Hoon Kim, Su-Hyun Kim, Jae-Won Hyun, Yeseul Kim, Hyewon Park, Ho Jin Ki. Seroprevalence of anti-myelin oligodendrocyte glycoprotein antibodies in adults with myelitis. Annals of clinical and translational neurology. 2022-08-06. PMID:35932473. |
although myelitis is the second most common presentation in adults with myelin oligodendrocyte glycoprotein (mog) antibody-associated disease (mogad), studies on mog-igg seroprevalence in patients with myelitis episodes are sparse. |
2022-08-06 |
2023-08-14 |
Not clear |